The Law Offices of Larry M. Roth, PA is an Orlando, Florida based law firm specializing in pharmaceutical litigation, complex commercial cases, and high exposure personal injury cases. Representing clients nationwide, this firm's principal focus is on two potentially hazardous drugs, Protopic and Elidel, and the makers of these drugs, Fujisawa (Astellas) and Novartis.
Mr. Roth and his team strive to provide progressive, effective and informed representation to clients who have suffered harm as the result of defective drugs. They feel that as lawyers they have the power to help protect and represent those who have been misled and subsequently endured unexpected illnesses. Through this fight they hope to right what is wrong.
Protopic and Elidel Info
Protopic (Tacrolimus) and Elidel (Pimecrolimus) are two popular steroid-free topical creams used in the treatment of the serious skin conditions Eczema and Atopic Dermatitis. Protopic was approved by the FDA in 2000; Elidel in 2001. These products are immunosuppresants and were to be only second line therapies, meaning they should not be prescribed by physicians unless the more traditional topical corticosteroids proved to be ineffective. Only if steroids did not work or could not be used would prescribing Protopic or Elidel be appropriate. Immunosuppressants can lower a person's normal immune system response making them more susceptible to disease.
In order to reinforce the restrictions of these drugs, a public health advisory was issued by the FDA to inform healthcare providers and patients about a potential cancer risk from use of Elidel and Protopic. In March 2005 the FDA required a "Black Box" warning for cancer on these approved drugs.
Despite these FDA warnings, the medical community and patients continue to underestimate the dangers of these two drugs. Unfortunately, the manufacturers of Protopic and Elidel have marketed these drugs without sufficient cancer warnings despite their knowledge of the lymphoma risks. Indeed, in the case of Protopic, pre-approval studies revealed the presence of incidences of lymphoma both in trial patients and animal studies.
Attorney Profile
Larry M. Roth, Esq
Mr. Roth was born in Knoxville, Tennessee. He attended University of Tennessee at Knoxville where he received his B.S. He then moved on to the University of Florida where he received his J.D. in 1975 and was admitted to the Florida state bar the same year. Currently, Mr. Roth is a member of the Orange County and American Bar Associations, The Florida Bar, Florida Bar Board of Legal Specialization and Education, and is an Associate Member of the American Trial Lawyers Association. He is a Board Certified Civil Trial Lawyer and a Certified Civil Mediator. Throughout his career, Mr. Roth has authored several articles and books for respected legal publications.
Mr. Roth's principles are simply stated: "To provide effective, aggressive, and well-prepared representation to all clients to preserve, protect and prosecute their rights."
Related Articles
Prescription Drugs Treating Skin Disease puts You and particularly Your
Children at Risk for Cancer.
By Larry M. Roth (copyright 2005-2006)
Press Release: Deadline For Legal Action Against The Manufacturers Of Protopic Or Elidel Is Approaching, According To Larry M. Roth (Dec-04-06)
Lawsuits Posted on LawyersandSettlements.com
Protopic Cream and Skin Cancer
Protopic (tacrolimus), is a topical ointment used in the treatment of eczema. Protopic should be used only on areas of skin that have eczema, and should not be used on normal skin. Protopic was approved by the FDA in December 2004.
Elidel and Skin Cancer
The U.S. Food and Drug Administration (FDA) recently issued a Public Health Advisory for users of Elidel while urging the medication manufacturers to add a black box warning to their eczema creams. The FDA's warning states, "It may take human studies of ten years or longer to determine if use of Elidel is linked to cancer."
